| Hematopoietic Stem Cell Transplantation | Lifetime | 15 | IT 1 | 99.89 |
| Acute Lymphoblastic Leukemia research | Lifetime | 23 | IT 2 | 99.84 |
| CAR-T cell therapy research | Lifetime | 62 | IT 3 | 99.72 |
| Immune Cell Function and Interaction | Lifetime | 215 | IT 5 | 99.72 |
| Mesenchymal stem cell research | Lifetime | 72 | IT 4 | 99.48 |
| Acute Myeloid Leukemia Research | Lifetime | 91 | IT 10 | 99.68 |
| Hemoglobinopathies and Related Disorders | Lifetime | 76 | IT 10 | 99.19 |
| Neuroblastoma Research and Treatments | Lifetime | 82 | IT 4 | 99.26 |
| Cytomegalovirus and herpesvirus research | Lifetime | 144 | IT 3 | 99.06 |
| Childhood Cancer Survivors' Quality of Life | Lifetime | 157 | IT 3 | 99.03 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 176 | IT 7 | 99.02 |
| Parvovirus B19 Infection Studies | Lifetime | 60 | IT 4 | 98.97 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 165 | IT 14 | 99.09 |
| T-cell and B-cell Immunology | Lifetime | 498 | IT 11 | 99.05 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 522 | IT 39 | 98.61 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 242 | IT 18 | 98.38 |
| Blood disorders and treatments | Lifetime | 185 | IT 8 | 97.56 |
| Prenatal Screening and Diagnostics | Lifetime | 378 | IT 16 | 97.90 |
| Polyomavirus and related diseases | Lifetime | 277 | IT 23 | 97.51 |
| Neutropenia and Cancer Infections | Lifetime | 253 | IT 14 | 97.66 |
| Blood groups and transfusion | Lifetime | 483 | IT 29 | 97.03 |
| Protein Tyrosine Phosphatases | Lifetime | 475 | IT 30 | 91.50 |
| Hemoglobinopathies and Related Disorders | 2021-2025 | 3 | IT 1 | 99.52 |
| Parvovirus B19 Infection Studies | 2021-2025 | 1 | IT 1 | 99.63 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 7 | IT 1 | 99.88 |
| CAR-T cell therapy research | 2021-2025 | 21 | IT 2 | 99.79 |
| Hematopoietic Stem Cell Transplantation | 2021-2025 | 10 | IT 2 | 99.61 |
| Immune Cell Function and Interaction | 2021-2025 | 46 | IT 1 | 99.07 |
| Neuroblastoma Research and Treatments | 2021-2025 | 14 | IT 3 | 98.97 |
| Virus-based gene therapy research | 2021-2025 | 27 | IT 3 | 98.28 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 24 | IT 3 | 99.46 |
| Prenatal Screening and Diagnostics | 2021-2025 | 35 | IT 5 | 97.92 |
| Acute Myeloid Leukemia Research | 2021-2025 | 128 | IT 11 | 98.73 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 66 | IT 4 | 97.77 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 275 | IT 16 | 96.99 |
| T-cell and B-cell Immunology | 2021-2025 | 269 | IT 2 | 92.96 |
| Cytomegalovirus and herpesvirus research | 2021-2025 | 249 | IT 11 | 89.78 |
| Childhood Cancer Survivors' Quality of Life | 2021-2025 | 649 | IT 19 | 91.09 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 370 | IT 50 | 91.82 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 979 | IT 62 | 92.13 |
| Sarcoma Diagnosis and Treatment | 2021-2025 | 909 | IT 92 | 87.19 |
| Neutropenia and Cancer Infections | 2021-2025 | 467 | IT 37 | 78.10 |
| Iron Metabolism and Disorders | 2021-2025 | 794 | IT 51 | 81.38 |
| Blood disorders and treatments | 2021-2025 | 379 | IT 47 | 75.61 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 764 | IT 77 | 72.46 |
